Cargando…
Post-Translational Modifications of BACE1 in Alzheimer's Disease
Beta-Amyloid Cleaving Enzyme1 (BACE1) is a monospecific enzyme for the key rate-limiting step in the synthesis of beta-amyloid(Aβ) from cleavage of amyloid precursor protein (APP), to form senile plaques and causes cognitive dysfunction in Alzheimer's disease (AD). Post-translation modification...
Autores principales: | Wen, Wen, Li, Ping, Liu, Panwang, Xu, Shijun, Wang, Fushun, Huang, Jason H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9199555/ https://www.ncbi.nlm.nih.gov/pubmed/33475074 http://dx.doi.org/10.2174/1570159X19666210121163224 |
Ejemplares similares
-
BACE1: A Key Regulator in Alzheimer’s Disease Progression and Current Development of its Inhibitors
por: Patel, Smith, et al.
Publicado: (2022) -
BACE1 Translation: At the Crossroads Between Alzheimer’s Disease Neurodegeneration and Memory Consolidation
por: Guix, Francesc X., et al.
Publicado: (2019) -
Antibody-Based In Vivo PET Imaging Detects Amyloid-β Reduction in Alzheimer Transgenic Mice After BACE-1 Inhibition
por: Meier, Silvio R., et al.
Publicado: (2018) -
Development and Structural Modification of BACE1 Inhibitors
por: Gu, Ting, et al.
Publicado: (2016) -
An aberrant sugar modification of BACE1 blocks its lysosomal targeting in Alzheimer's disease
por: Kizuka, Yasuhiko, et al.
Publicado: (2015)